Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Proteomic network analysis of human uterine smooth muscle in pregnancy, labor, and preterm labor.

Ulrich C, Quilici DR, Schlauch KA, Buxton IL.

Integr Mol Med. 2015 Aug;2(4):261-269.

2.

Blockade of extracellular NM23 or its endothelial target slows breast cancer growth and metastasis.

Yokdang N, Nordmeier S, Speirs K, Burkin HR, Buxton IL.

Integr Cancer Sci Ther. 2015;2(4):192-200.

3.

Alternatively Spliced Human TREK-1 Variants Alter TREK-1 Channel Function and Localization.

Cowles CL, Wu YY, Barnett SD, Lee MT, Burkin HR, Buxton IL.

Biol Reprod. 2015 Nov;93(5):122. doi: 10.1095/biolreprod.115.129791.

4.

LC/MS/MS data analysis of the human uterine smooth muscle S-nitrosoproteome fingerprint in pregnancy, labor, and preterm labor.

Ulrich CC, Quilici DR, Schlauch KA, Burkin HR, Buxton IL.

Data Brief. 2015 Aug 1;4:591-4. doi: 10.1016/j.dib.2015.07.031.

5.

The human uterine smooth muscle S-nitrosoproteome fingerprint in pregnancy, labor, and preterm labor.

Ulrich C, Quilici DR, Schlauch KA, Buxton IL.

Am J Physiol Cell Physiol. 2013 Oct 15;305(8):C803-16. doi: 10.1152/ajpcell.00198.2013.

6.

TREK-1 currents in smooth muscle cells from pregnant human myometrium.

Heyman NS, Cowles CL, Barnett SD, Wu YY, Cullison C, Singer CA, Leblanc N, Buxton IL.

Am J Physiol Cell Physiol. 2013 Sep 15;305(6):C632-42. doi: 10.1152/ajpcell.00324.2012.

7.

Integrin upregulation and localization to focal adhesion sites in pregnant human myometrium.

Burkin HR, Rice M, Sarathy A, Thompson S, Singer CA, Buxton IL.

Reprod Sci. 2013 Jul;20(7):804-12. doi: 10.1177/1933719112466303.

8.

Variants of stretch-activated two-pore potassium channel TREK-1 associated with preterm labor in humans.

Wu YY, Singer CA, Buxton IL.

Biol Reprod. 2012 Oct 25;87(4):96. doi: 10.1095/biolreprod.112.099499.

9.

Extracellular NM23 Signaling in Breast Cancer: Incommodus Verum.

Buxton IL, Yokdang N.

Cancers (Basel). 2011 Sep;3(3):2844-57. doi: 10.3390/cancers3032844.

10.

Uterine smooth muscle S-nitrosylproteome in pregnancy.

Ulrich C, Quillici DR, Schegg K, Woolsey R, Nordmeier A, Buxton IL.

Mol Pharmacol. 2012 Feb;81(2):143-53. doi: 10.1124/mol.111.075804.

11.

A role of stretch-activated potassium currents in the regulation of uterine smooth muscle contraction.

Buxton IL, Heyman N, Wu YY, Barnett S, Ulrich C.

Acta Pharmacol Sin. 2011 Jun;32(6):758-64. doi: 10.1038/aps.2011.62. Review.

12.

A role for nucleotides in support of breast cancer angiogenesis: heterologous receptor signalling.

Yokdang N, Tellez JD, Tian H, Norvell J, Barsky SH, Valencik M, Buxton IL.

Br J Cancer. 2011 May 10;104(10):1628-40. doi: 10.1038/bjc.2011.134.

13.

Expression of stretch-activated two-pore potassium channels in human myometrium in pregnancy and labor.

Buxton IL, Singer CA, Tichenor JN.

PLoS One. 2010 Aug 25;5(8):e12372. doi: 10.1371/journal.pone.0012372.

14.

Agonist-specific compartmentation of cGMP action in myometrium.

Buxton IL, Milton D, Barnett SD, Tichenor SD.

J Pharmacol Exp Ther. 2010 Oct;335(1):256-63. doi: 10.1124/jpet.110.171934.

15.

Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis.

Buxton IL, Yokdang N, Matz RM.

Cancer Lett. 2010 May 28;291(2):131-41. doi: 10.1016/j.canlet.2009.09.021. Review.

16.

Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis.

Rumjahn SM, Yokdang N, Baldwin KA, Thai J, Buxton IL.

Br J Cancer. 2009 May 5;100(9):1465-70. doi: 10.1038/sj.bjc.6604998.

17.
18.

Validation of the CSI health station 6K blood pressure kiosk.

Buxton IL, Adams JQ, Gore M, Sullivan CR.

Proc West Pharmacol Soc. 2007;50:181-3.

19.

P2y receptor-mediated angiogenesis via vascular endothelial growth factor receptor 2 signaling.

Rumjahn SM, Baldwin KA, Buxton IL.

Proc West Pharmacol Soc. 2007;50:58-60.

20.
Items per page

Supplemental Content

Loading ...
Support Center